Merck Kgaa Company Profile
What is the competitive landscape for MERCK KGAA
MERCK KGAA has one approved drug.
Summary for Merck Kgaa
| US Patents: | 0 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
| Patent Litigation for Merck Kgaa: | See patent lawsuits for Merck Kgaa |
Drugs and US Patents for Merck Kgaa
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Merck Kgaa | LEVOTHYROXINE SODIUM | levothyroxine sodium | TABLET;ORAL | 076752-007 | Jun 16, 2005 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Merck Kgaa | LEVOTHYROXINE SODIUM | levothyroxine sodium | TABLET;ORAL | 076752-003 | Jun 16, 2005 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Merck Kgaa | LEVOTHYROXINE SODIUM | levothyroxine sodium | TABLET;ORAL | 076752-009 | Jun 16, 2005 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Merck Kgaa | LEVOTHYROXINE SODIUM | levothyroxine sodium | TABLET;ORAL | 076752-005 | Jun 16, 2005 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Merck Kgaa | LEVOTHYROXINE SODIUM | levothyroxine sodium | TABLET;ORAL | 076752-010 | Jun 16, 2005 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Paragraph IV (Patent) Challenges for MERCK KGAA drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | for Injection | 100 mcg/vial and 500 mcg/vial | ➤ Subscribe | 2015-04-14 |
| ➤ Subscribe | for Injection | 200 mcg/vial | ➤ Subscribe | 2015-05-01 |
Similar Applicant Names
Here is a list of applicants with similar names.

